Xolair Related Clinical Trials
Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids [Completed]
The Effect of Xolair (Omalizumab) on Allergy Blood Cells [Recruiting]
Effect of Xolair on Airway Hyperresponsiveness [Recruiting]
Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab [Terminated]
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair [Recruiting]
Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy [Completed]
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model [Recruiting]
The Safety and Utility of Skin Testing With Xolair (Omalizumab) and Placebo Omalizumab (Formulation Excipients) [Recruiting]
OIT and Xolair� (Omalizumab) in Cow's Milk Allergy [Recruiting]
Efficacy and Safety of Omalizumab in Bullous Pemphigoid [Recruiting]
A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma [Completed]
Xolair Enhances Oral Desensitization in Peanut Allergic Patients [Recruiting]
Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis [Recruiting]
Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria [Not yet recruiting]
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels [Recruiting]
Cold Urticaria Treatment With Xolair [Recruiting]
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations [Recruiting]
Xolair Treatment for Milk Allergic Children [Recruiting]
Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis [Withdrawn]
Omalizumab in the Treatment of Peanut Allergy [Recruiting]
Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria [Recruiting]
Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization [Recruiting]
mRNA Expression as a Biomarker of Omalizumab Response [Not yet recruiting]
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial [Recruiting]
Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children [Recruiting]
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge [Recruiting]
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy [Recruiting]
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis [Recruiting]
Omalizumab in Non-atopic Asthma [Recruiting]
Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage [Recruiting]
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [Recruiting]
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment [Recruiting]
The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients [Recruiting]
An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g [Completed]
Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy [Not yet recruiting]
Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) [Recruiting]
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists [Recruiting]
Non-invasive Measures of Effects of Xolair in Asthma [Recruiting]
A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) [Recruiting]
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) [Recruiting]
Omalizumab for Lupus [Recruiting]
A Safety and Efficacy Study of Xolair in Peanut Allergy [Terminated]
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies [Completed]
A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g [Active, not recruiting]
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma [Recruiting]
An Observational Study of the Use and Safety of Xolair During Pregnancy [Recruiting]
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Recruiting]
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab [Recruiting]
The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils [Active, not recruiting]
Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis [Active, not recruiting]
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma [Recruiting]
The Effect of Omalizumab on Responses to Cat Allergen Challenge [Recruiting]
Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma [Recruiting]
Xolair in Patients With Chronic Sinusitis [Recruiting]
A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy [Enrolling by invitation]
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma [Recruiting]
Omalizumab to Treat Hyper-IgE (Job's) Syndrome [Recruiting]
Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. [Completed]
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma [Not yet recruiting]
Efficacy and Safety of Omalizumab in Children (6 - <12 Years) With Moderate-Severe, Inadequately Controlled Allergic Asthma [Active, not recruiting]
Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma [Completed]
Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma [Recruiting]
Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients [Completed]
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma [Not yet recruiting]
Omalizumab to Treat Eosinophilic Gastroenteritis [Active, not recruiting]
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma [Completed]
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma [Recruiting]
Study of Omalizumab in Moderate to Severe Bronchial Asthma [Completed]
A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO) [Completed]
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma [Active, not recruiting]
Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma [Completed]
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by ABPA [Recruiting]
A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels [Recruiting]
A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-Induced Asthma (AERO) [Recruiting]
A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma [Active, not recruiting]
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-Agonists [Recruiting]
A Study to Evaluate the Efficacy of Xolair in Atopic Asthmatics [Recruiting]
A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma (AQUA) [Recruiting]
Effect of Anti-IgE in Chronic Urticaria [Completed]
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria Who Exhibit IgE Against Thyreoperoxidase [Recruiting]
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma [Active, not recruiting]
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing [Not yet recruiting]
Soluble CD23 Expression in Asthma Patients Treated With OMA [Terminated]
ICATA Asthma Mechanistic Study [Active, not recruiting]
Inner-City Anti-IgE Therapy for Asthma
A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy [Recruiting]
Impact of Asthma Treatments on Daily Activities [Recruiting]
Effect of Anti-IgE in Non-Allergic Asthma [Recruiting]
Immune Dysfunction in Allergic Asthma [Recruiting]
|
